<sup>225</sup>Actinium-labeled prostate-specific membrane antigen targeting peptide induces complete response in a metastatic prostate cancer patient.

Aras, Omer; Harmsen, Stefan; Ting, Richard; Sayman, Haluk B

²²⁵Actinium-labeled prostate-specific membrane antigen targeting peptide induces complete response in a metastatic prostate cancer patient.

Aras, Omer; Harmsen, Stefan; Ting, Richard; Sayman, Haluk B.

Afiliação

Aras O; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.
Harmsen S; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, School of Medicine Stanford University, Stanford, USA.
Ting R; Molecular Imaging Innovations Institute (MI3), Department of Radiology, Weill Cornell Medical College, New York, USA.
Sayman HB; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Acta Radiol Open ; 10(5): 20584601211022509, 2021 May.

Article em En | MEDLINE | ID: mdl-34104479

Palavras-chave

225Ac-PSMA; genetic alterations; metastatic prostate cancer; radioligand therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Acta Radiol Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google